Masterclass series in peripheral arterial disease: Acquired thrombophilia

Michael Greaves

Research output: Contribution to journalEditorial

Abstract

Peripheral arterial occlusion is a significant complication of several haematological and other systemic disorders (Table 1).

In each of these conditions there is a hypercoagulable state, although the pathogenetic mechanisms leading to thrombosis vary. Acute arterial events tend to occur in subjects with additional risk factors or who already have atherosclerotic disease. They are not confined to the peripheral circulation. In contrast to the inherited thrombophilias in the acquired thrombophilic conditions, there is generally a predisposition to both arterial and venous thromboembolism, and in some conditions to microvascular thrombosis.

Original languageEnglish
Pages (from-to)215-218
Number of pages3
JournalVascular Medicine
Volume9
Issue number3
DOIs
Publication statusPublished - 2004

Keywords

  • ANTIPHOSPHOLIPID-ANTIBODY-SYNDROME
  • ACTIVATED PROTEIN-C
  • MYELOPROLIFERATIVE DISORDERS
  • CONTROLLED TRIAL
  • THROMBOSIS
  • ASPIRIN
  • EFFICACY
  • COFACTOR
  • HEPARIN
  • SAFETY

Cite this

Masterclass series in peripheral arterial disease: Acquired thrombophilia. / Greaves, Michael.

In: Vascular Medicine, Vol. 9, No. 3, 2004, p. 215-218.

Research output: Contribution to journalEditorial

Greaves, Michael. / Masterclass series in peripheral arterial disease: Acquired thrombophilia. In: Vascular Medicine. 2004 ; Vol. 9, No. 3. pp. 215-218.
@article{305f1683ec164567b4ce97aaa89e167d,
title = "Masterclass series in peripheral arterial disease: Acquired thrombophilia",
abstract = "Peripheral arterial occlusion is a significant complication of several haematological and other systemic disorders (Table 1).In each of these conditions there is a hypercoagulable state, although the pathogenetic mechanisms leading to thrombosis vary. Acute arterial events tend to occur in subjects with additional risk factors or who already have atherosclerotic disease. They are not confined to the peripheral circulation. In contrast to the inherited thrombophilias in the acquired thrombophilic conditions, there is generally a predisposition to both arterial and venous thromboembolism, and in some conditions to microvascular thrombosis.",
keywords = "ANTIPHOSPHOLIPID-ANTIBODY-SYNDROME, ACTIVATED PROTEIN-C, MYELOPROLIFERATIVE DISORDERS, CONTROLLED TRIAL, THROMBOSIS, ASPIRIN, EFFICACY, COFACTOR, HEPARIN, SAFETY",
author = "Michael Greaves",
year = "2004",
doi = "10.1191/1358863x04vm533xx",
language = "English",
volume = "9",
pages = "215--218",
journal = "Vascular Medicine",
issn = "1358-863X",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Masterclass series in peripheral arterial disease: Acquired thrombophilia

AU - Greaves, Michael

PY - 2004

Y1 - 2004

N2 - Peripheral arterial occlusion is a significant complication of several haematological and other systemic disorders (Table 1).In each of these conditions there is a hypercoagulable state, although the pathogenetic mechanisms leading to thrombosis vary. Acute arterial events tend to occur in subjects with additional risk factors or who already have atherosclerotic disease. They are not confined to the peripheral circulation. In contrast to the inherited thrombophilias in the acquired thrombophilic conditions, there is generally a predisposition to both arterial and venous thromboembolism, and in some conditions to microvascular thrombosis.

AB - Peripheral arterial occlusion is a significant complication of several haematological and other systemic disorders (Table 1).In each of these conditions there is a hypercoagulable state, although the pathogenetic mechanisms leading to thrombosis vary. Acute arterial events tend to occur in subjects with additional risk factors or who already have atherosclerotic disease. They are not confined to the peripheral circulation. In contrast to the inherited thrombophilias in the acquired thrombophilic conditions, there is generally a predisposition to both arterial and venous thromboembolism, and in some conditions to microvascular thrombosis.

KW - ANTIPHOSPHOLIPID-ANTIBODY-SYNDROME

KW - ACTIVATED PROTEIN-C

KW - MYELOPROLIFERATIVE DISORDERS

KW - CONTROLLED TRIAL

KW - THROMBOSIS

KW - ASPIRIN

KW - EFFICACY

KW - COFACTOR

KW - HEPARIN

KW - SAFETY

U2 - 10.1191/1358863x04vm533xx

DO - 10.1191/1358863x04vm533xx

M3 - Editorial

VL - 9

SP - 215

EP - 218

JO - Vascular Medicine

JF - Vascular Medicine

SN - 1358-863X

IS - 3

ER -